Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial - Concepedia

Concepedia

Publication | Open Access

Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial

DOI Full Paper Access

221

Citations

25

References

2018

Year

Paul Lyon, Michael Gray, Christophoros Mannaris, Lisa K. Folkes, Michael R.L. Stratford, Leticia Campo, Daniel Y. F. Chung, S. Scott, Mark Anderson, Robert Goldin,

The Lancet Oncology

References

	Year	Citations

Page 1